Aditxt Inc. Subsidiary Pearsanta Advances in DoD-Funded Ovarian Cancer Diagnostic Study
Aditxt Inc.'s subsidiary Pearsanta moves forward in a Department of Defense-funded study for early ovarian cancer detection, highlighting the potential impact on women's health diagnostics.
